Cargando…
Reply: Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
Autores principales: | Choudry, Fizzah A., Rathod, Krishnaraj S., Baumbach, Andreas, Mathur, Anthony, Jones, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834880/ https://www.ncbi.nlm.nih.gov/pubmed/33413933 http://dx.doi.org/10.1016/j.jacc.2020.11.004 |
Ejemplares similares
-
Long-Term Outcomes of COVID-19-Associated ST-Elevation Myocardial Infarction Treated With Primary PCI
por: Choudry, Fizzah A., et al.
Publicado: (2022) -
Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
por: Martin, Anne-Céline, et al.
Publicado: (2021) -
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction
por: Choudry, Fizzah A., et al.
Publicado: (2020) -
COVID-19 and changes in activity and treatment of ST elevation MI from a UK cardiac centre
por: Chen, Yang, et al.
Publicado: (2021) -
Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
por: Centurión, Osmar Antonio
Publicado: (2016)